Skip to search formSkip to main contentSkip to account menu

CYP2D6*4 Allele

Known as: CYP2D6, g.1846G>A, Cytochrome P450, Family 2, Subfamily D, Polypeptide 6*4 Allele, CYP2D6(B) 
Human CYP2D6*4 allele is located in the vicinity of 22q13.1 and is approximately 4 kb in length. This allele, a variant form of the CYP2D6 wild-type… 
National Institutes of Health

Related topics

Related topics

12 relations
22q13.1Guanosine to Adenosine Transition AbnormalityInactive - Biochemical Activity LevelIron Chelation

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Understanding CYP 2 D 6 and Its Role in Tamoxifen Metabolism
547 T he gene CYP2D6 has an extremely important role in drug metabolism. “Cytochrome P450, family 2, subfamily D, polypeptide 6… 
2016
2016
Incidence of inactive allele CYP2D6*4 among Greek women suffering from hormone-sensitive breast cancer.
BACKGROUND The incidence of CYP2D6*4 among Caucasians is estimated up to 27%, while it is present in up to 90% of all poor… 
2010
2010
Selections from a literature search on the effects , mechanism of action , and metabolism of mCPP , the principal metabolite of Trazodone , with references
Trazodone, a triazolepyridine derivate, is both chemically and pharmacologically distinct from other serotonin reuptake… 
2010
2010
02社-3P-K29 梨大方式園庭芝生化プロジェクトの試み : 大学生、園児、保育者、保護者の共同作業によるポット苗方式による園庭芝生化(02.体育社会学,一般研究発表抄録)
2010
2010
09方-1P-K29 バイオメカニクスから見た空手道競技の評価基準に関する検討 : 基本動作における「動作のキレ」に着目して(09.体育方法,一般研究発表抄録)
2007
2007
Association of genetic variants and the susceptibility to abnormal involuntary movements and tardive dyskinesia (TD) in Xhosa schizophrenia patients
No obvious explanations exist for the development of abnormal involuntary movements (AIM), but several hypotheses have been… 
2003
2003
idiopathic Parkinson ' s disease . a population of German patients with The CYP 2 D 6 B allele is not overrepresented in
Received 28 September 1995 and in final revised form 22 May 1996 Accepted 3 June 1996 Abstract The frequency of the CYP2D6B… 
1999
1999
GENETIC BIAS COULD NOT BE IGNORED IN CLINICAL TRIALS
AIM: To evaluate if there is a genetic bias in clinical trials. METHODS: Genotyping of the CYP2D6A, CYP2D6B, CYP2D6D, CYP2D6E and… 
1998
1998
PCR and RFLP-based CYP2D6(B) and CYP2D6(T) Genotyping for Korean Lung Cancer Cases and Controls
The genetically determined CYP2D6 activity as considered to be associated with cancer susceptibility with inter-individual… 
1978
1978
[原著]ウェルシュ菌 K29 株の産生するバクテリオシンおよび溶菌物質の精製とその性状